All Stories

  1. Updating a conceptual model of effective symptom management in palliative care to include patient and carer perspective: a qualitative study

    Article • BMC Palliative Care, August 2024, Springer Science + Business Media

    Emma Chapman

  2. Narrative review: what constitutes contemporary, high-quality end-of-life care and can lessons be learned from medieval history?

    Article • Annals of Palliative Medicine, May 2024, AME Publishing Company

    Emma Chapman

  3. Evaluating provision of psychological assessment and support in palliative care: A national survey of hospices in England

    Article • Progress in Palliative Care, November 2023, Taylor & Francis

    Emma Chapman

  4. Non-pharmacological interventions to manage psychological distress in patients living with cancer: a systematic review

    Article • BMC Palliative Care, July 2023, Springer Science + Business Media

    Dr Carole A Paley, Emma Chapman

  5. Characteristics of good home-based end-of-life care: analysis of 5-year data from a nationwide mortality follow-back survey in England

    Article • British Journal of General Practice, December 2022, Royal College of General Practitioners

    Emma Chapman

  6. Patient experiences of living with cancer before interaction with palliative care services in Zimbabwe: A qualitative secondary data analysis

    Article • European Journal of Cancer Care, June 2022, Wiley

    Emma Chapman

  7. Does ethnicity affect pain management for people with advanced disease? A mixed methods cross-national systematic review of ‘very high’ Human Development Index English-speaking countries

    Article • BMC Palliative Care, April 2022, Springer Science + Business Media

    Emma Chapman

  8. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review

    Article • Palliative Medicine, March 2022, SAGE Publications

    Emma Chapman

  9. P-77 How does age, sex, ethnicity and diagnosis affect the pain reported by palliative care patients in a hospice setting?

    Article • March 2022, BMJ

    Emma Chapman

  10. Practice review: Evidence-based and effective management of fatigue in patients with advanced cancer

    Article • Palliative Medicine, December 2021, SAGE Publications

    Emma Chapman

  11. Understanding the role of hospice pharmacists: a qualitative study

    Article • International Journal of Clinical Pharmacy, June 2021, Springer Science + Business Media

    Emma Chapman

  12. A national survey of hospice pharmacists and a comparison with international models

    Article • International Journal of Pharmacy Practice, April 2021, Oxford University Press (OUP)

    Emma Chapman

  13. Duration of palliative care before death in international routine practice: a systematic review and meta-analysis

    Article • BMC Medicine, November 2020, Springer Science + Business Media

    Emma Chapman

  14. Identification of patients with potential palliative care needs: A systematic review of screening tools in primary care

    Article • Palliative Medicine, June 2020, SAGE Publications

    Emma Chapman

  15. Practice review: Evidence-based and effective management of pain in patients with advanced cancer

    Article • Palliative Medicine, January 2020, SAGE Publications

    Emma Chapman

  16. SIRT1 in bladder cancer

    Article • European Journal of Cancer, July 2016, Elsevier

    Emma Chapman

  17. Polycomb Repressor Complex 1 Member, BMI1 Contributes to Urothelial Tumorigenesis through p16-Independent Mechanisms

    Article • Translational Oncology, October 2015, Elsevier

    Emma Chapman

  18. 619: Overexpression of BMI-1 immortalises normal human urothelial cells

    Article • European Journal of Cancer, July 2014, Elsevier

    Emma Chapman

  19. Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer

    Article • British Journal of Cancer, April 2013, Springer Science + Business Media

    Emma Chapman

  20. Necdin: A multi functional protein with potential tumor suppressor role?

    Article • Molecular Carcinogenesis, November 2009, Wiley

    Emma Chapman

  21. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC)

    Article • Genes Chromosomes and Cancer, August 2009, Wiley

    Emma Chapman

  22. Conditioned medium from Ad-IFN-α-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect

    Article • Cancer Gene Therapy, July 2008, Springer Science + Business Media

    Emma Chapman

  23. Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells

    Article • Molecular Cancer Research, July 2008, American Association for Cancer Research (AACR)

    Emma Chapman

  24. Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway

    Article • Oncogene, April 2006, Springer Science + Business Media

    Emma Chapman

  25. Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical Phenotype

    Article • Clinical Cancer Research, August 2005, American Association for Cancer Research (AACR)

    Emma Chapman

  26. Improved measurement of p16 and p14ARF gene dosage in bladder tumours by quantitative real time PCR

    Article • European Urology Supplements, September 2003, Elsevier

    Emma Chapman